Skip to main content
Caplight Logo









UCANACT

UCANACT

Private
UtrechtHealthcare & Life Scienceshttps://www.ucanact.com/

Last Round

Pre Seed

Sep 20, 2026

Total Funding Raised

$1.03M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

UCANACT is a neurotechnology company that develops a device-agnostic brain-computer interface platform to enable communication and device control for individuals with severe motor disabilities.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, NLP & Conversational AI

Business Model

B2B

Customer Profile

Services & Consulting, Hardware + Subscription

AI Layer

Application

Keywords

brain-computer interfaceBCIneural decodingassistive technologyneurotechnologybrain-machine interfacemedical AIdigital autonomyspeech synthesisneural signal processingmedical device softwareaugmentative communicationneuroprostheticsbioelectronics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

UCANACT Comparables

Compare UCANACT with similar companies based on industry and business-model similarity.

UCANACT comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neuralink
70%
Tether
69%
Paradromics
68%

UCANACT Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 20, 2026

UCANACT Investors

Notable investors and investment history

UCANACT investors
InvestorRounds
LUMO LabsPre Seed
Netherlands Organization for Scientific ResearchGrant
Utrecht HoldingsPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 20, 2026

    $918K round led by LUMO Labs and Utrecht Holdings.

Recent news

Latest coverage and updates

  • receives_financingSep 20, 2026

    Ucanact received financing of $918K in Pre Seed on Sep 20th '26.

  • is_developingSep 15, 2026

    Ucanact is developing brain-computer interface on Sep 15th '26.

UCANACT Filings

Explore SEC and related filing metadata, where available.

UCANACT filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about UCANACT's valuation, stock price, and market status.

Is UCANACT a public or private company?

UCANACT is a private company.

What is the current stock price of UCANACT?

UCANACT is a private company with no public stock price. Caplight tracks UCANACT's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is UCANACT worth (valuation)?

Valuation information for UCANACT is not publicly available.

Can I buy UCANACT stock?

UCANACT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was UCANACT's last funding round?

UCANACT's most recent funding round was Pre Seed on September 20, 2026.

Who are the main investors in UCANACT?

Key investors in UCANACT include LUMO Labs, Utrecht Holdings.

Will UCANACT IPO soon?

No public IPO plans have been announced for UCANACT.

How can I track UCANACT secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor UCANACT's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUtrecht
Year Founded2025
Last FundingSep 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?